$399.35
-9.41-2.30%
At close: -
$399.55
0.200.05%
After Hours: 6:18 PM EDT
Comments
Loading...
Latest news for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock
Vertex Pharmaceuticals Stock (NASDAQ: VRTX)
Categories: All
Thursday, December 26, 2024
Monday, December 23, 2024
- Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst
- Microsoft To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday
- Truist Securities Maintains Buy on Vertex Pha...
- Scotiabank Maintains Sector Perform on Vertex...
- JP Morgan Maintains Overweight on Vertex Phar...
Sunday, December 22, 2024
Friday, December 20, 2024
Thursday, December 19, 2024
Wednesday, December 18, 2024
Monday, December 16, 2024
Friday, December 13, 2024
Tuesday, December 10, 2024
Monday, December 09, 2024
Wednesday, December 04, 2024
Monday, November 25, 2024
Monday, November 18, 2024
Friday, November 15, 2024
Thursday, November 14, 2024
Wednesday, November 06, 2024
Tuesday, November 05, 2024
- Scotiabank Maintains Sector Perform on Vertex...
- Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
- Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
- UBS Maintains Buy on Vertex Pharmaceuticals, ...
- Cantor Fitzgerald Reiterates Overweight on Ve...
- RBC Capital Maintains Sector Perform on Verte...
- JP Morgan Maintains Overweight on Vertex Phar...
- Vertex Pharmaceuticals shares are trading hig...
- Assessing Vertex Pharmaceuticals: Insights From 11 Financial Analysts
- Morgan Stanley Maintains Equal-Weight on Vert...
Monday, November 04, 2024
- Vertex Pharmaceuticals Sees FY 2024 Product R...
- Vertex Pharmaceuticals Q3 2024 Adj EPS $4.38 ...
- Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
- Jim Cramer Says Vertex Doing 'Lord's Work': Can Q3 Earnings Outshine Bearish Charts?